Despite comprehensive statistical analyses of clinical data revealing no significant correlation between heightened FTO protein expression and various characteristics of endometrial cancer—including patient age, disease stage, tumor grade, extent of infiltration, and lymph node metastasis—high levels of FTO are nevertheless associated with a poorer prognosis and earlier recurrence in affected patients (54). This evidence concerns the gene FTO and endometrial cancer.